PMID- 36809516
OWN - NLM
STAT- MEDLINE
DCOM- 20230224
LR  - 20231127
IS  - 2194-7236 (Electronic)
IS  - 2194-7228 (Linking)
VI  - 51
IP  - 1
DP  - 2023 Feb 21
TI  - Ureteroscopic and flexible ureteroscopic lithotripsy: continuation or 
      discontinuation of anticoagulant or antiplatelet drugs? A Chinese survey among 
      urologists.
PG  - 39
LID - 10.1007/s00240-023-01413-x [doi]
AB  - PURPOSE: To evaluate the management of antithrombotic drugs made by different 
      urologists before ureteroscopic lithotripsy and flexible ureteroscopy in stone 
      patients undergoing active anticoagulant or antiplatelet therapy. METHODS: A 
      survey was distributed to 613 urologists in China, which included personal work 
      information and views on the management of anticoagulants (AC) or antiplatelet 
      (AP) drugs during the perioperative period of ureteroscopic lithotripsy (URL) and 
      flexible ureteroscopy (fURS). RESULTS: 20.5% of urologists believed that AP drugs 
      could be continued and 14.7% believed that AC drugs could be continued. 26.1% of 
      the urologists who participated in more than 100 ureteroscopic lithotripsy or 
      flexible ureteroscopy surgeries each year believed that AP drugs could be 
      continued and 19.1% believed that AC drugs could be continued, compared with 
      13.6% (P < 0.01) and 9.2% (P < 0.01) of the urologists who performed less than 
      100 surgeries. Among the urologists with more than 20 cases undergoing active AC 
      or AP therapy per year, 25.9% thought that AP drugs could be continued and 19.7% 
      thought that AC drugs could be continued, compared with 17.1% (P = 0.008) and 
      11.5% (P = 0.005) of the urologists with less than 20 cases. CONCLUSION: The 
      decision on the continuation of AC or AP drugs before ureteroscopic and flexible 
      ureteroscopic lithotripsy should be individualized. The experience in URL and 
      fURS surgeries and in dealing with patients under AC or AP therapy is the 
      influencing factor.
CI  - (c) 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, 
      part of Springer Nature.
FAU - Xu, Zi-Jie
AU  - Xu ZJ
AD  - Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University 
      School of Medicine, Shanghai, China.
FAU - Chen, Lei
AU  - Chen L
AD  - Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University 
      School of Medicine, Shanghai, China.
FAU - Li, Deng
AU  - Li D
AD  - Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University 
      School of Medicine, Shanghai, China.
FAU - Xu, Chao-Liang
AU  - Xu CL
AD  - Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University 
      School of Medicine, Shanghai, China.
FAU - Chen, Fei-Teng
AU  - Chen FT
AD  - Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University 
      School of Medicine, Shanghai, China.
FAU - Tang, Qi-Lin
AU  - Tang QL
AD  - Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University 
      School of Medicine, Shanghai, China.
FAU - Shao, Yi
AU  - Shao Y
AD  - Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University 
      School of Medicine, Shanghai, China. drshaoyi@163.com.
AD  - Shanghai Municipal Alliance in Urology, Shanghai, China. drshaoyi@163.com.
LA  - eng
GR  - 20Y11904600/Science and Technology Commission of Shanghai Municipality/
GR  - 2020PJD046/Shanghai Pujiang Program/
GR  - 18sjkjgg13/Science and Technology Commission of Songjiang District/
PT  - Journal Article
DEP - 20230221
PL  - Germany
TA  - Urolithiasis
JT  - Urolithiasis
JID - 101602699
RN  - 0 (Anticoagulants)
RN  - 0 (Platelet Aggregation Inhibitors)
SB  - IM
MH  - Humans
MH  - Anticoagulants
MH  - *Kidney Calculi/surgery
MH  - *Lithotripsy
MH  - Platelet Aggregation Inhibitors
MH  - Treatment Outcome
MH  - *Ureteral Calculi/therapy
MH  - *Ureteroscopy
MH  - Urologists
MH  - China
OTO - NOTNLM
OT  - Anticoagulant drugs antiplatelet drugs
OT  - Flexible ureteroscopy
OT  - Ureteroscopic lithotripsy
EDAT- 2023/02/23 06:00
MHDA- 2023/02/25 06:00
CRDT- 2023/02/22 13:51
PHST- 2022/10/01 00:00 [received]
PHST- 2023/02/11 00:00 [accepted]
PHST- 2023/02/22 13:51 [entrez]
PHST- 2023/02/23 06:00 [pubmed]
PHST- 2023/02/25 06:00 [medline]
AID - 10.1007/s00240-023-01413-x [pii]
AID - 10.1007/s00240-023-01413-x [doi]
PST - epublish
SO  - Urolithiasis. 2023 Feb 21;51(1):39. doi: 10.1007/s00240-023-01413-x.